| Market Cap | ₹61,632Cr |
| ROE | 33.41% |
| P/E Ratio(TTM) | 42.44 |
| EPS(TTM) | 683.43 |
| P/B Ratio | 14.56 |
| Dividend Yield | 1.64% |
| Industry P/E | 40.62 |
| Book Value | 1992.07 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Abbott India Limited |
| Managing Director | Mr. Vivek Kamath |
| NSE Symbol | ABBOTINDIA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 46.79 | ||
| Astrazeneca Pharma India | NA (0.00%) | 130.02 | ||
| Pfizer | NA (0.00%) | 29.46 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 55.46 |